NHI Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 1.83%, SMA50 7.97%, SMA200 14.85%). The stock’s 14-day RSI is 59.7 (neutral), while the ATR of 1.88 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -3.88% below its high and over 32.25% above its low. Average 10-day trading volume of 328.73 thousand shares is slightly above the 3-month average of 259.36 thousand, indicating heightened recent market interest.

National Health Investors, Inc. (NYSE:NHI) closed at $82.56 USD, gaining $0.24 (0.29%) from the previous close of $82.32. The stock is currently mid-range between its 52-week high and low $66.41 and $91.38. With a market capitalization of about $4.00 billion, National Health Investors, Inc. is classified as a mid-cap and shows lower-than-market volatility (beta ~0.66). Key stats such as the average daily volume over the past year has been around 270.81 thousand shares, in line with its 52-week average. Headquartered in Murfreesboro, TN, National Health Investors, Inc. operates in the Real Estate sector and the REIT - Healthcare Facilities industry. Led by CEO D. Eric Mendelsohn, the company employs approximately 30 people and listed since October 09, 1991. Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments.

National Health Investors, Inc. last paid a dividend of 3.64 per share, this equals a trailing yield of roughly 5.15%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $201.89. This means the shares are trading below this model’s fair value.

National Health Investors, Inc. generated EPS of $3.17 over the past year. Five-year average earnings growth is -3.17%. Wall Street analysts project EPS growth of 4.09% annually over the next five years. The latest quarter delivered EPS of $1.32. The next quarter is forecast at $0.79. Next year's EPS is expected at -$8.69. Analyst sentiment is bullish. Analyst rating data shows there are 3 Strong Buy ratings, 3 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $92.00 to $80.00. The high target offers 11.43% upside. The low target suggests -3.1% downside. The mean target is $84.88. This offers 2.81% upside. National Health Investors, Inc. earnings surprise history is a mixed track record. The quarter that ended November 06, 2025, missed forecasts by 6.45%. The prior quarter beat by 5.17%. Over the last six quarters, Apple has recorded several small beats. These include -26.36% in August 06, 2024.

National Health Investors, Inc. has 48.39 million shares outstanding. The public float is 43.86 million shares, elevated short interest at 3.34% of float. This equals 1.35 million shares. The short ratio is 5.56 days. Institutional investors hold 76.75% of the float. Insiders own 2.17%. ADAMS W ANDREW holds 759.78 thousand shares, ADAMS ROBERT G has 180.55 thousand shares and SWAFFORD CHARLOTTE A has 110.18 thousand shares.

National Health Investors, Inc. trades at a P/E ratio of 27.37, slightly below the S&P 500 average, with a price-to-sales ratio of 10.69 and a price-to-book ratio of 2.56 suggesting the stock is closer to book value. The P/FCF stands at 18.12, also above market averages.

Our AI price prediction model suggests that National Health Investors, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -2.75%, with price expected at $80.29 by April 06, 2026, within a range of $78.45 to $82.21 3-Month Outlook: Projected rise of 29.25%, reaching $106.71 by June 19, 2026, with a range of $102.25 to $111.92. 1-Year Outlook: Projected gain of 15.58%, with price at $95.42 by March 23, 2027, within a range of $93.64 to $97.62.

National Health Investors, Inc. (NYSE:NHI) shares are flat 4.36% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows National Health Investors, Inc. trading at a premium to the broader market with a P/E of 27.37. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $70.28, suggesting -14.87% downside. Our AI forecast model points to short-term weakness (-2.75% over two weeks), a medium-term rise (29.25% over three months), and a longer-term gain (15.58% over one year), with expected trading ranges indicating moderate volatility.